Period | Status | L | F | n (alleles) | (f) L1014F | 95% CI | N | Y | n (alleles) | (f) N1575Y | 95% CI |
---|---|---|---|---|---|---|---|---|---|---|---|
VK7 | |||||||||||
Jul-11 | Control | 22 | 102 | 124 | 0.823 | 0.744-0.886 | 80 | 44 | 124 | 0.355 | 0.276-0.442 |
Dead | 23 | 97 | 120 | 0.808 | 0.728-0.870 | 92 | 34 | 126 | 0.270 | 0.200-0.354 | |
Survivors | 19 | 95 | 114 | 0.833 | 0.754-0.892 | 80 | 30 | 110 | 0.273 | 0.198-0.363 | |
Oct-11 | Control | 27 | 163 | 190 | 0.858 | 0.801-0.901 | 134 | 56 | 190 | 0.295 | 0.234-0.363 |
Dead | 42 | 194 | 236 | 0.822 | 0.768-0.866 | 174 | 60 | 234 | 0.256 | 0.205-0.316 | |
Survivors | 15 | 133 | 148 | 0.899* | 0.839-0.939 | 91 | 55 | 146 | 0.377* | 0.302-0.458 | |
Jun-12 | Control | 25 | 183 | 208 | 0.880 | 0.828-0.918 | 151 | 55 | 206 | 0.267 | 0.211-0.331 |
Dead | 9 | 45 | 54 | 0.833 | 0.710-0.912 | 42 | 12 | 54 | 0.222 | 0.131-0.351 | |
Survivors | 14 | 132 | 146 | 0.904 | 0.844-0.943 | 90 | 56 | 146 | 0.384* | 0.309-0.465 | |
Jul-13 | Control | 16 | 126 | 142 | 0.887 | 0.823-0.934 | 109 | 33 | 142 | 0.232 | 0.166-0.311 |
Tengrela | |||||||||||
Jul-12 | Control | 14 | 100 | 114 | 0.877 | 0.803-0.931 | 87 | 27 | 114 | 0.237 | 0.162-0.326 |
Dead | 18 | 80 | 98 | 0.816 | 0.725-0.887 | 66 | 32 | 98 | 0.327 | 0.235-0.429 | |
Survivors | 11 | 81 | 92 | 0.880 | 0.796-0.939 | 66 | 26 | 92 | 0.283 | 0.194-0.386 | |
Jul-13 | Control | 24 | 124 | 148 | 0.838 | 0.768-0.893 | 109 | 39 | 148 | 0.264 | 0.194-0.342 |